The enzyme HDAC10 is involved in a variety of cellular processes associated with the development of a number of diseases. However, it is often not known exactly what role HDAC10 plays in the disease process. Scientists from the German Cancer Research Center (DKFZ) have now for the first time synthesized a highly selective inhibitor that can be used to study the function of HDAC10. Their research appears in the Journal of the American Chemical Society.
Click here for original story, A specific inhibitor allows researchers to study an enigmatic enzyme
Source: Phys.org